Steven H. Collis will retire as president and CEO of Cencora Inc., one of the region's largest public companies, on Oct. 1. As part of a succession plan announced Tuesday, Collis will be replaced by Cencora Chief Operating Officer Robert Mauch, who will also join the company's board of directors. Collis will remain with the Conshohocken-based wholesale pharmaceutical company as its executive chairman.

Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the “Notes”), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the “SEC”) on November 23, 2021.